HK1083503A1 - Novel pyrimidine-4, 6-dicarboxamides for the selective inhibition of collagenases - Google Patents
Novel pyrimidine-4, 6-dicarboxamides for the selective inhibition of collagenasesInfo
- Publication number
- HK1083503A1 HK1083503A1 HK06103488A HK06103488A HK1083503A1 HK 1083503 A1 HK1083503 A1 HK 1083503A1 HK 06103488 A HK06103488 A HK 06103488A HK 06103488 A HK06103488 A HK 06103488A HK 1083503 A1 HK1083503 A1 HK 1083503A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- dicarboxamides
- collagenases
- selective inhibition
- novel pyrimidine
- pyrimidine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10251019A DE10251019A1 (en) | 2002-11-02 | 2002-11-02 | New pyrimidine-4,6-dicarboxamide derivatives, are selective collagenase inhibitors useful e.g. for treating degenerative joint diseases, connective tissue disorders or cancer |
| DE10254092A DE10254092A1 (en) | 2002-11-20 | 2002-11-20 | New pyrimidine-4,6-dicarboxamide derivatives, are selective collagenase inhibitors useful e.g. for treating degenerative joint diseases, connective tissue disorders or cancer |
| PCT/EP2003/011515 WO2004041788A1 (en) | 2002-11-02 | 2003-10-18 | Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1083503A1 true HK1083503A1 (en) | 2006-07-07 |
Family
ID=32313538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK06103488A HK1083503A1 (en) | 2002-11-02 | 2006-03-20 | Novel pyrimidine-4, 6-dicarboxamides for the selective inhibition of collagenases |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP1560815B1 (en) |
| JP (1) | JP4564359B2 (en) |
| KR (1) | KR101050680B1 (en) |
| AR (1) | AR043058A1 (en) |
| AT (1) | ATE388941T1 (en) |
| AU (1) | AU2003301847A1 (en) |
| BR (1) | BR0315055A (en) |
| CA (1) | CA2504153C (en) |
| CO (1) | CO5700759A2 (en) |
| DE (1) | DE50309381D1 (en) |
| DK (1) | DK1560815T3 (en) |
| ES (1) | ES2298621T3 (en) |
| HK (1) | HK1083503A1 (en) |
| HR (1) | HRP20050382B1 (en) |
| MA (1) | MA27412A1 (en) |
| MX (1) | MXPA05004365A (en) |
| MY (1) | MY135375A (en) |
| NO (1) | NO330345B1 (en) |
| PE (1) | PE20040605A1 (en) |
| PL (1) | PL375044A1 (en) |
| PT (1) | PT1560815E (en) |
| RS (1) | RS20050294A (en) |
| RU (1) | RU2344129C2 (en) |
| TW (1) | TWI316512B (en) |
| WO (1) | WO2004041788A1 (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060173183A1 (en) * | 2004-12-31 | 2006-08-03 | Alantos Pharmaceuticals, Inc., | Multicyclic bis-amide MMP inhibitors |
| JP5463034B2 (en) * | 2005-05-20 | 2014-04-09 | アラントス・フアーマシユーテイカルズ・ホールデイング・インコーポレイテツド | Pyrimidine or triazine fused bicyclic metalloprotease inhibitors |
| US20070155738A1 (en) | 2005-05-20 | 2007-07-05 | Alantos Pharmaceuticals, Inc. | Heterobicyclic metalloprotease inhibitors |
| CA2658362A1 (en) * | 2006-06-29 | 2008-01-03 | Alantos Pharmaceuticals Holding, Inc. | Metalloprotease inhibitors |
| US8563573B2 (en) | 2007-11-02 | 2013-10-22 | Vertex Pharmaceuticals Incorporated | Azaindole derivatives as CFTR modulators |
| TWI444379B (en) | 2007-06-29 | 2014-07-11 | Sunesis Pharmaceuticals Inc | Compounds useful as raf kinase inhibitors |
| AR068509A1 (en) * | 2007-09-19 | 2009-11-18 | Jerini Ag | BRADIQUININE B1 RECEIVER ANTAGOSNIST |
| US8912184B1 (en) | 2010-03-01 | 2014-12-16 | Alzheimer's Institute Of America, Inc. | Therapeutic and diagnostic methods |
| US8802868B2 (en) | 2010-03-25 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide |
| MX2012012204A (en) | 2010-04-22 | 2012-12-05 | Vertex Pharma | Process of producing cycloalkylcarboxamido-indole compounds. |
| AR086113A1 (en) | 2011-04-30 | 2013-11-20 | Abbott Lab | ISOXAZOLINS AS THERAPEUTIC AGENTS |
| CN110840847B (en) | 2014-04-15 | 2022-07-29 | 沃泰克斯药物股份有限公司 | Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3931432A1 (en) * | 1989-09-21 | 1991-04-04 | Hoechst Ag | PYRIMIDIN-4,6-DICARBONSAEUREDIAMIDE, METHOD FOR THE PRODUCTION AND USE THEREOF AND MEDICINAL PRODUCTS BASED ON THESE COMPOUNDS |
| DE60236851D1 (en) * | 2001-02-14 | 2010-08-12 | Warner Lambert Co | Pyrimidinmatrixmetalloproteinaseinhibitoren |
| DOP2002000332A (en) * | 2001-02-14 | 2002-08-30 | Warner Lambert Co | MATRIX METALOPROTEINAS PYRIDINE INHIBITORS |
| DE10160357A1 (en) * | 2001-12-08 | 2003-06-18 | Aventis Pharma Gmbh | Use of pyridine-2,4-dicarboxylic acid diamides and pyrimidine-4,6-dicarboxylic acid diamides for the selective inhibition of collagenases |
-
2003
- 2003-10-18 DE DE50309381T patent/DE50309381D1/en not_active Expired - Lifetime
- 2003-10-18 KR KR1020057007598A patent/KR101050680B1/en not_active IP Right Cessation
- 2003-10-18 RS YUP-2005/0294A patent/RS20050294A/en unknown
- 2003-10-18 AU AU2003301847A patent/AU2003301847A1/en not_active Abandoned
- 2003-10-18 EP EP03810401A patent/EP1560815B1/en not_active Expired - Lifetime
- 2003-10-18 PT PT03810401T patent/PT1560815E/en unknown
- 2003-10-18 BR BR0315055-0A patent/BR0315055A/en not_active Application Discontinuation
- 2003-10-18 ES ES03810401T patent/ES2298621T3/en not_active Expired - Lifetime
- 2003-10-18 PL PL03375044A patent/PL375044A1/en unknown
- 2003-10-18 AT AT03810401T patent/ATE388941T1/en active
- 2003-10-18 MX MXPA05004365A patent/MXPA05004365A/en active IP Right Grant
- 2003-10-18 RU RU2005116847/04A patent/RU2344129C2/en not_active IP Right Cessation
- 2003-10-18 WO PCT/EP2003/011515 patent/WO2004041788A1/en active IP Right Grant
- 2003-10-18 CA CA2504153A patent/CA2504153C/en not_active Expired - Fee Related
- 2003-10-18 DK DK03810401T patent/DK1560815T3/en active
- 2003-10-18 JP JP2004548752A patent/JP4564359B2/en not_active Expired - Fee Related
- 2003-10-27 PE PE2003001085A patent/PE20040605A1/en not_active Application Discontinuation
- 2003-10-29 TW TW092129976A patent/TWI316512B/en not_active IP Right Cessation
- 2003-10-30 AR ARP030103974A patent/AR043058A1/en not_active Application Discontinuation
- 2003-10-30 MY MYPI20034144A patent/MY135375A/en unknown
-
2005
- 2005-04-29 MA MA28244A patent/MA27412A1/en unknown
- 2005-04-29 CO CO05041024A patent/CO5700759A2/en not_active Application Discontinuation
- 2005-04-29 HR HRP20050382AA patent/HRP20050382B1/en not_active IP Right Cessation
- 2005-05-31 NO NO20052628A patent/NO330345B1/en not_active IP Right Cessation
-
2006
- 2006-03-20 HK HK06103488A patent/HK1083503A1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2298621T3 (en) | 2008-05-16 |
| AU2003301847A1 (en) | 2004-06-07 |
| TWI316512B (en) | 2009-11-01 |
| TW200418808A (en) | 2004-10-01 |
| PE20040605A1 (en) | 2004-10-15 |
| PL375044A1 (en) | 2005-11-14 |
| MA27412A1 (en) | 2005-06-01 |
| JP2006513158A (en) | 2006-04-20 |
| RS20050294A (en) | 2007-11-15 |
| KR101050680B1 (en) | 2011-07-21 |
| DK1560815T3 (en) | 2008-06-16 |
| CA2504153A1 (en) | 2004-05-21 |
| EP1560815B1 (en) | 2008-03-12 |
| CA2504153C (en) | 2012-07-03 |
| WO2004041788A1 (en) | 2004-05-21 |
| NO330345B1 (en) | 2011-03-28 |
| HRP20050382B1 (en) | 2013-09-30 |
| DE50309381D1 (en) | 2008-04-24 |
| NO20052628D0 (en) | 2005-05-31 |
| ATE388941T1 (en) | 2008-03-15 |
| HRP20050382A2 (en) | 2006-12-31 |
| RU2344129C2 (en) | 2009-01-20 |
| MY135375A (en) | 2008-04-30 |
| MXPA05004365A (en) | 2005-07-05 |
| CO5700759A2 (en) | 2006-11-30 |
| JP4564359B2 (en) | 2010-10-20 |
| PT1560815E (en) | 2008-04-07 |
| RU2005116847A (en) | 2006-01-20 |
| AR043058A1 (en) | 2005-07-13 |
| EP1560815A1 (en) | 2005-08-10 |
| BR0315055A (en) | 2005-08-16 |
| KR20050067212A (en) | 2005-06-30 |
| NO20052628L (en) | 2005-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1083503A1 (en) | Novel pyrimidine-4, 6-dicarboxamides for the selective inhibition of collagenases | |
| ZA200502210B (en) | Substrates for O6-alkylguanine-DNA alkyltansferase. | |
| PL376129A1 (en) | Pyridazinone derivatives as gsk-3beta inhibitors | |
| ZA200409339B (en) | Novel benzimidazole derivatives. | |
| AU2003216660A1 (en) | N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors | |
| IL165046A0 (en) | Pyrimidinone compounds, compositions and methods | |
| AP2005003198A0 (en) | Spiroindolinepiperidine derivatives. | |
| ZA200500170B (en) | Indole-3-sulphur derivatives. | |
| AU2003219410A8 (en) | Triaryl-oxy-aryl-spiro-pyrimidine-2, 4, 6-trione metalloproteinase inhibitors | |
| ZA200407666B (en) | Pyridinoylpiperidines as 5-HTif agonists. | |
| ZA200307646B (en) | Benzamidine derivative. | |
| SI1555267T1 (en) | 2,3-DIHYDRO-6-NITROIMIDAZOS2,1-bCOXAZOLES | |
| ZA200409641B (en) | Novel substituted indoles. | |
| IL163817A0 (en) | 2,4-Diaminopyrimidine | |
| MX267068B (en) | Symmetrical triazine derivatives. | |
| AU2003216677A1 (en) | Triaryl-oxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors | |
| IL169318A0 (en) | Pyrimidines, methods for the production thereof, and use thereof | |
| MX263097B (en) | Small molecule entry inhibitors. | |
| IL164377A0 (en) | Methods of preparation of the 2-(7-chloro-1,8-naphthyridine-2yl)-3-(5-methyl-2-oxo-hexyl)-1-isoindolinone | |
| GB0215256D0 (en) | I.t | |
| ZA200407363B (en) | Novel compounds. | |
| ZA200306866B (en) | Matches. | |
| ZA200408338B (en) | Heterocyclic compounds. | |
| GB0212492D0 (en) | D.I.Y. workvest | |
| TW545437U (en) | Abstract of the disclosure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20141018 |